Description

Save Your Sight: Bimat Eye Drops Bimatoprost 0.03%

What Are Bimat Eye Drops?

Bimat Eye Drops are a prescription-only ophthalmic solution (eye drops for clinical use). Each millilitre contains bimatoprost 0.03% w/v as the active ingredient.

Bimat Eye Drops are bioequivalent to Lumigan, the widely recognised UK reference brand, which also contains bimatoprost 0.03%.

Different brand names for bimatoprost may be encountered in regulated UK pharmacies. This is completely normal as they contain the same active ingredient. Bimat Eye Drops contain the same active ingredient and work in the same clinically established way.

Classified as a prescription-only medicine (POM), bimatoprost is dispensed exclusively through regulated pharmacies. A valid prescription verified by a qualified UK clinician is required before supply.

Bimat Eye Drops vs Lumigan: Scientific Comparison

Detail	Bimat Eye Drops	Lumigan
Active Ingredient	Bimatoprost	Bimatoprost
Strength	0.03% w/v	0.03% w/v
Chemical Class	Prostaglandin analogue	Prostaglandin analogue
Mechanism of Action	Prostaglandin F2-alpha receptor agonist	Prostaglandin F2-alpha receptor agonist
Bioequivalence	Yes — same active ingredient and strength	Reference brand
Therapeutic Effect	Lowers intraocular pressure	Lowers intraocular pressure
Manufacturer	Ajanta Pharma Limited	Allergan (AbbVie)
Prescription Status	Prescription-Only Medicine (POM)	Prescription-Only Medicine (POM)

Both medicines contain bimatoprost 0.03% and deliver the same pharmacological effect. Your clinician or ophthalmologist will advise which is appropriate for your treatment plan.

Composition

Active Ingredient

Bimatoprost 0.03% w/v

Manufacturer

Ajanta Pharma Limited.

Available Variants

• Bimat Eye Drops
• Bimat T
• Bimat LS eye drops
• Bimat LS TM

Expiry

Typically 24–36 months from the date of manufacture. Check the actual expiry date printed on each pack before use.

How Bimatoprost Works in the Eye

Bimatoprost is a prostaglandin F2-alpha receptor agonist (a medicine that activates specific receptors to regulate fluid pressure). By promoting a greater outflow of aqueous humour — the fluid that circulates within the eye — intraocular pressure is reduced through bimatoprost’s mechanism of action.

When this fluid drains more effectively, intraocular pressure (IOP, the pressure inside the eye) falls. Because persistently elevated IOP places ongoing pressure on the optic nerve, irreversible vision loss can develop if the condition is left unmanaged.

By keeping IOP within a clinically safe range, bimatoprost helps protect the optic nerve from progressive damage. It does not cure glaucoma but manages it effectively with consistent daily use.

Clinical Uses of Bimat Eye Drops

The clinical conditions for which Bimat Eye Drops are prescribed include open-angle glaucoma and ocular hypertension.

• Bimat Eye Drops are indicated for open-angle glaucoma, the most prevalent form of the condition in the UK, where fluid drainage from the eye is impaired.
• They are also prescribed for ocular hypertension — raised IOP in the absence of optic nerve damage — which carries an elevated risk of glaucoma development.
• A further aim of treatment is preventing optic nerve damage arising from sustained raised IOP.

Symptoms These Eye Drops Address

Bimat Eye Drops help manage the following symptoms associated with raised IOP:

• Eye redness
• Mild to moderate eye pain
• Pressure-related heaviness or fullness

Like any medicine, side effects may be experienced.

• Blurred vision and eye irritation or discomfort are among those most frequently reported.

Because early discontinuation can allow IOP to rise again, completing the full prescribed course is essential to prevent optic nerve damage.

Clinical Benefits of Bimat Eye Drops

Bimat Eye Drops effectively lower raised intraocular pressure when used as directed. This is the primary therapeutic goal in managing glaucoma and ocular hypertension.

Stable IOP control reduces the risk of progressive optic nerve deterioration. Because consistent daily application maintains stable intraocular pressure, visual function is preserved more effectively over the long term.

For patients with ocular hypertension, early treatment with bimatoprost can delay or prevent the onset of glaucoma. Once-daily application supports consistent pressure control throughout the day and evening.

How to Use Bimat Eye Drops Correctly

Follow your ophthalmologist’s instructions carefully for each application.

1. Before and after applying the drops, hands must be washed thoroughly to minimise the risk of contamination
2. A small pocket is created by tilting the head back and gently pulling the lower eyelid downward
3. Keeping the dropper close to the eye without allowing it to touch the surface reduces the risk of contamination
4. Only the number of drops specified in the prescription should be applied at each dose
5. Once the drops have been applied, closing the eyes for one to two minutes supports effective absorption. Excessive blinking during this period must be avoided
6. Excess liquid can be carefully removed using a clean tissue, while the dropper tip must be kept away from all surfaces to prevent contamination.

Do not swallow the drops. Use externally for the eye only. Even where symptoms appear to improve, the drops must continue to be used exactly as directed by the prescribing clinician.

Safety

Side Effects of Bimat Eye Drops

Side Effect	Type	Action Required
Mild eye irritation or burning after application	Common — Temporary	Monitor; inform doctor if persistent
Conjunctival redness (redness of the white of the eye)	Common — Temporary	Monitor; inform doctor if persistent
Watery or itchy eyes	Common — Temporary	Monitor; inform doctor if persistent
Dryness of the eye surface	Common — Temporary	Monitor; inform doctor if persistent
Gradual eyelash growth or darkening	Common — Temporary	Inform doctor at next appointment
Slight darkening of the eyelid skin	Common — Temporary	Inform doctor at next appointment
Increased iris pigmentation (permanent darkening of eye colour)	Rare — Serious	Inform doctor promptly; effect may be permanent
Eye inflammation — uveitis (swelling inside the eye)	Rare — Serious	Seek medical advice immediately
Significant or sudden vision changes	Rare — Serious	Seek urgent medical attention immediately
Severe allergic reactions — swelling, skin rash, or breathing difficulty	Rare — Serious	Call 999 or go to A&E immediately

Stop using Bimat Eye Drops immediately if you develop severe irritation, vision loss, or facial swelling. Seek urgent medical attention without delay.

Contraindications — Who Should Not Use Bimat Eye Drops

Certain patients must not use Bimat Eye Drops.

• Bimat Eye Drops must not be used by those with a known allergy to bimatoprost or any prostaglandin analogue.
• Use without prior assessment by a qualified ophthalmologist is also contraindicated.
• Unless a doctor has explicitly prescribed this medicine, use during pregnancy or whilst breastfeeding must be avoided.

Before treatment begins, a full medical history must be disclosed to the prescribing clinician to ensure safe and appropriate prescribing.

Drug Interactions

Tell your ophthalmologist about all medicines you currently use. This includes other eye drops, systemic medicines, and herbal remedies.

Because different eye preparations can interfere with one another, a minimum gap of five minutes between applications is required when more than one eye drop is being used. This allows full absorption and prevents one medicine from washing out the other.

Some medicines may affect how bimatoprost works. Before any new treatment is started, interactions can be identified by the clinician or pharmacist, allowing potential risks to be addressed in advance.

Liver and Kidney Considerations

No major interactions between Bimat Eye Drops and liver disease are currently established. However, patients with hepatic impairment (reduced liver function) discuss with your GP or specialist should use bimatoprost under close medical supervision.

Alcohol

Alcohol has no direct interaction with Bimat Eye Drops. However, excessive alcohol intake may worsen ocular dryness or irritation.

Driving 

Because bimatoprost can cause temporary blurred vision immediately after application, driving or operating machinery should not be attempted until vision has returned fully to normal.

Pregnancy

During pregnancy, Bimat Eye Drops should only be used where they have been clearly prescribed by a doctor following careful clinical assessment. Limited human safety data are available. The potential benefit must outweigh the risk to the unborn baby.
Before these drops are used whilst breastfeeding, advice must be sought from a GP or specialist. Systemic absorption (the amount entering the bloodstream) is low. Caution is still advised.

Reporting Side Effects — UK Yellow Card Scheme

If you experience any unexpected side effects whilst using Bimat Eye Drops, report them through the MHRA Yellow Card Scheme. This supports ongoing UK medicine safety monitoring.

Visit: yellowcard.mhra.gov.uk

Before starting or changing any eye treatment, consultation with a qualified UK healthcare professional is required.

Safety and Usage Warnings

Before using Bimat Eye Drops, follow these important precautions:

• Before the bottle is handled, thorough handwashing is essential to minimise the risk of contamination.
• Before first use, the tamper-evident seal should be checked to confirm it is intact.
• Sharing eye drops with another person carries a risk of infection and cross-contamination and must not be done under any circumstances.
• Any prior allergic reactions to prostaglandin analogues should be disclosed to the prescriber.
• The full prescribed course must be completed unless the prescribing clinician advises otherwise.

Contact lens wearers

Contact lenses must always be removed prior to the application of Bimat Eye Drops. A minimum of fifteen minutes should pass before reinsertion. Because the preservative benzalkonium chloride is capable of being absorbed by soft contact lenses, irritation can result if this step is skipped.

Missed Dose Guidance

Where a dose has been missed, it should be applied at the earliest opportunity once remembered. Where the next scheduled dose is almost due, the missed application should be skipped entirely rather than applied late. Double-dosing must not be used to compensate for a missed application. The pharmacist should be contacted if any uncertainty remains.

When to Speak to a Doctor

Contact your GP if you notice symptoms that worsen or fail to improve with consistent use.

• Swelling, rash, or intense irritation may indicate an allergic reaction, meaning that urgent medical attention must be sought without delay
• New or worsening sensitivity to light
• A history of eye surgery, uveitis, or other ocular conditions

Because stopping treatment without guidance can cause IOP to rise, Bimat Eye Drops must not be discontinued without first speaking to the prescribing clinician. Stopping suddenly may cause IOP to rise rapidly.

Additional Pharmacological Information

Parameter	Details
Habit Forming	No
Chemical Class	Prostaglandin analogue
Therapeutic Class	Ophthalmic anti-glaucoma agent
Action Class	Prostaglandin F2-alpha receptor agonist
Prescription Status	Prescription-only medicine (POM)
Manufacturer	Ajanta Pharma Limited

Accessing Bimat Eye Drops Responsibly in the UK

Bimat Eye Drops are a prescription-only medicine. They cannot be supplied without a valid prescription from a qualified UK clinician.

Do not attempt to obtain bimatoprost without a valid prescription. Obtaining or using ophthalmic medicines without a valid prescription can cause serious and irreversible harm to vision.

FAQs

Q: What is the use of Bimat eye drops?

A: Raised intraocular pressure is lowered by Bimat Eye Drops, which are used in the treatment of open-angle glaucoma and ocular hypertension. They protect the optic nerve and prevent vision loss.

Q: What are the side effects of Bimat?

A: Among the side effects reported most frequently are eye irritation, redness, and watering. Iris darkening occurs less frequently. Persistent or severe symptoms should always be reported to the prescribing doctor without delay.

Q: How quickly do Bimat eye drops work?

A: Bimat Eye Drops begin reducing eye pressure within a few hours. Peak pressure-lowering effect is reached between 8 and 12 hours after application, meaning that several weeks of consistent use may be needed before the full clinical benefit is achieved.

Conclusion

Containing bimatoprost 0.03%, Bimat Eye Drops act as a prostaglandin analogue to lower raised intraocular pressure effectively. Prescription for open-angle glaucoma and ocular hypertension is issued under the supervision of a qualified UK ophthalmologist. Stable pressure control depends on consistent daily use. Regular ophthalmological review is necessary to confirm ongoing treatment effectiveness and to monitor for side effects.

References

• The College of Optometrists. Glaucoma. Available at: www.college-optometrists.org
• National Institute for Health and Care Excellence (NICE). (2022). Glaucoma: diagnosis and management. NG81. Available at: www.nice.org.uk
• Medicines and Healthcare products Regulatory Agency (MHRA). Yellow Card Scheme. Available at: www.yellowcard.mhra.gov.uk
• NHS. (2024). Glaucoma. Available at: www.nhs.uk

Medical Disclaimer

This article is for informational purposes only and does not replace professional medical advice. Always consult a registered healthcare professional before starting or changing any treatment. Always consult a registered UK healthcare professional before using Bimat Eye Drops or any comparable ophthalmic medicine.